MaaT Pharma SA (EPA:MAAT)
France
· Delayed Price · Currency is EUR 5.89
+0.02 (0.34%)
Apr 29, 2026, 2:38 PM CET
MaaT Pharma Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 24.87 | 20.15 | 24.28 | 35.25 | 43.31 | Upgrade
|
| Short-Term Investments | - | - | - | 0.06 | - | Upgrade
|
| Cash & Short-Term Investments | 24.87 | 20.15 | 24.28 | 35.31 | 43.31 | Upgrade
|
| Cash Growth | 23.39% | -16.99% | -31.24% | -18.46% | 117.47% | Upgrade
|
| Accounts Receivable | 5.19 | 5.03 | 5.16 | 4.24 | 2.39 | Upgrade
|
| Other Receivables | 1.63 | 1.12 | 1.04 | 0.78 | 0.98 | Upgrade
|
| Receivables | 6.82 | 6.15 | 6.21 | 5.02 | 3.37 | Upgrade
|
| Inventory | 0.08 | 0.06 | 0.19 | 0.05 | 0.03 | Upgrade
|
| Prepaid Expenses | 1.05 | 1.07 | 1.13 | 1.58 | 0.43 | Upgrade
|
| Other Current Assets | 0.18 | 0.21 | 0.19 | 0.16 | 0.13 | Upgrade
|
| Total Current Assets | 32.99 | 27.64 | 31.99 | 42.12 | 47.27 | Upgrade
|
| Property, Plant & Equipment | 7.34 | 8.6 | 9.17 | 0.97 | 1.11 | Upgrade
|
| Long-Term Investments | - | - | - | - | 0.1 | Upgrade
|
| Other Intangible Assets | 1.84 | 1.77 | 1.34 | 1.2 | 0.81 | Upgrade
|
| Long-Term Deferred Charges | 2 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | - | 0.2 | 0.2 | 0.3 | - | Upgrade
|
| Total Assets | 44.55 | 38.5 | 42.93 | 44.73 | 49.42 | Upgrade
|
| Accounts Payable | 11.81 | 8.83 | 6.35 | 4.51 | 2.47 | Upgrade
|
| Accrued Expenses | 1.86 | 1.99 | 1.29 | 1.24 | 0.69 | Upgrade
|
| Current Portion of Long-Term Debt | 1.16 | 1.85 | 2.22 | 2.77 | 1.06 | Upgrade
|
| Current Portion of Leases | 1.34 | 1.28 | 1.23 | 0.21 | 0.19 | Upgrade
|
| Current Income Taxes Payable | 0.08 | 0.09 | 0.06 | 0.05 | 0.03 | Upgrade
|
| Current Unearned Revenue | 0.21 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 0.52 | 0.53 | 0.37 | 0.44 | 0.25 | Upgrade
|
| Total Current Liabilities | 16.98 | 14.56 | 11.52 | 9.22 | 4.7 | Upgrade
|
| Long-Term Debt | 11.26 | 8.11 | 5.75 | 7.94 | 3.98 | Upgrade
|
| Long-Term Leases | 3.69 | 4.72 | 4.88 | 0.43 | 0.57 | Upgrade
|
| Pension & Post-Retirement Benefits | 0.21 | 0.17 | 0.17 | 0.1 | 0.12 | Upgrade
|
| Other Long-Term Liabilities | 10.62 | 0.6 | 0.15 | 0.23 | 0.19 | Upgrade
|
| Total Liabilities | 42.75 | 28.17 | 22.47 | 17.92 | 9.56 | Upgrade
|
| Common Stock | 1.89 | 1.4 | 1.16 | 0.99 | 0.99 | Upgrade
|
| Additional Paid-In Capital | 28.77 | 35.48 | 37.38 | 38.32 | 46.46 | Upgrade
|
| Retained Earnings | -28.65 | -26.3 | -17.86 | -12.37 | -7.6 | Upgrade
|
| Treasury Stock | -0.21 | -0.23 | -0.22 | -0.14 | - | Upgrade
|
| Shareholders' Equity | 1.8 | 10.34 | 20.47 | 26.81 | 39.86 | Upgrade
|
| Total Liabilities & Equity | 44.55 | 38.5 | 42.93 | 44.73 | 49.42 | Upgrade
|
| Total Debt | 17.44 | 15.96 | 14.08 | 11.36 | 5.81 | Upgrade
|
| Net Cash (Debt) | 7.43 | 4.2 | 10.21 | 23.95 | 37.5 | Upgrade
|
| Net Cash Growth | 76.96% | -58.87% | -57.39% | -36.13% | 171.00% | Upgrade
|
| Net Cash Per Share | 0.47 | 0.32 | 0.90 | 2.42 | 15.45 | Upgrade
|
| Filing Date Shares Outstanding | 18.84 | 16.08 | 11.6 | 11.54 | 9.89 | Upgrade
|
| Total Common Shares Outstanding | 18.82 | 13.95 | 11.59 | 9.94 | 9.88 | Upgrade
|
| Working Capital | 16.02 | 13.08 | 20.47 | 32.91 | 42.57 | Upgrade
|
| Book Value Per Share | 0.10 | 0.74 | 1.77 | 2.70 | 4.03 | Upgrade
|
| Tangible Book Value | -0.05 | 8.57 | 19.12 | 25.61 | 39.05 | Upgrade
|
| Tangible Book Value Per Share | -0.00 | 0.61 | 1.65 | 2.58 | 3.95 | Upgrade
|
| Machinery | 1.11 | 1.35 | 1.24 | 0.99 | 0.73 | Upgrade
|
| Construction In Progress | 0.74 | 0.56 | 0.52 | 0.07 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.